Effects of Ethyl-Eicosapentaenoate in Patients with Ongoing Depression – (11-21-02)

Effects of Ethyl-Eicosapentaenoate in Patients with Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs

1 gram/day of EPA shows a dramatic improvement in depressive ratings for patients in this small study with no side effects. This is not the first trial to show a benefit for essential fatty acids and psychological health.

A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate….

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: